Replies to post #390927 on Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

Do you think Leo still wants to license individual B indications, or is he ready to sell the entire B platform?

Your focus on "the payer analysis" suggests the former, but for which indication?

Oral Mucositis?